Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RG1068 (Secretin) in Schizophrenia
NCT00235274Phase 2Completed
- Sponsor
- Indiana University School of Medicine
- Start
- Nov 2005
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of secretin in schizophrenia, sponsored by Indiana University School of Medicine. Started Nov 2005; status: completed.
02
Drugs
secretin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00235274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235274.